Discover 1,087 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oregon provides numerous opportunities for both healthy volunteers and individuals with specific health conditions to get involved in paid medical research. With major research centers in Portland, Eugene, and Salem actively recruiting, participants can access the latest in treatment options and medical innovation.
Filter
1
Filter results
Results: 1,087
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
for
Advanced Biliary Tract Carcinoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT07405086
Phase 4, Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase 3, Recruiting
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
for
GIST - Gastrointestinal Stromal Tumor, GIST,
Location: Boston MA, Lake Success NY, Philadelphia PA,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07406633
Phase 2, Recruiting
Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking
for
Smoking Behaviors
Location: Portland OR
Sponsor: Kaiser Permanente
Sex: All
Age: 18+
Code: NCT07459621
Recruiting
Using EMA Data to Inform a Web-intervention for Couples Concerned About Drinking
for
Alcohol; Use, Problem
Location: Portland OR
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT06501677
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: Halifax, Providence RI, New Haven CT, Lake Success NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase 3, Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Location: Norwich CT, Guilford CT, North Haven CT, New Haven CT,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07421700
Phase 1, Phase 2, Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Quebec, Westbury NY, New York NY, Montreal, Norfolk VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361497
Phase 3, Recruiting
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Newark DE, Baltimore MD, Washington D.C. DC,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07154290
Phase 2, Recruiting
Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services
for
Language Delay, Substance Use Disorders,
Location: Eugene OR
Sponsor: University of Oregon
Sex: All
Age: 18+
Code: NCT07529327
Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
Location: Montreal, Charlottesville VA, Toronto, Jacksonville FL,
Sponsor: RayzeBio, Inc.
Sex: All
Age: 18+
Code: NCT07165132
Phase 1, Recruiting
Brief Sleep Intervention for Bedtime Resistance
for
Child Sleep
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 18+
Code: NCT06970392
Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
for
Obesity or Overweight
Location: Boston MA, Needham MA, New Haven CT, Quebec,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351045
Phase 3, Recruiting
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
for
Macular Telangiectasia Type 2 (MacTel)
Location: Bloomfield NJ, Frederick MD, Cleveland OH, Knoxville TN,
Sponsor: Neurotech Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06971939
Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Location: Burlington MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04840602
Phase 2, Recruiting
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies